Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2009-009429-26Phase 4Completed
Phase 4, randomised, open-label trial of human chorionic gonadotropin and buserelin in endometrial receptivity disorder and luteal insufficiency (4 arms), sponsored by Vrije Universiteit Brussel. Primary endpoints: Endometrial receptivity parameters and Luteal phase characteristics. Started Mar 2009; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2009-009429-26.